WebMar 9, 2024 · Ironwood Pharmaceuticals stock has received a consensus rating of hold. The average rating score is and is based on 1 buy ratings, 3 hold ratings, and 0 sell ratings. WebSep 27, 2024 · Oleg Elkov/iStock via Getty Images. Investment Thesis. Ironwood Pharmaceuticals (NASDAQ:IRWD) is a gastrointestinal health care company that is best known for its market leading product, LINZESS ...
IRWD:NASDAQ GS Stock Quote - Ironwood Pharmaceuticals Inc - Bloo…
WebIRONWOOD PHARMACEUTICALS, INC. 2010 EMPLOYEE STOCK PURCHASE PLAN . The following constitute the provisions of the 2010 Employee Stock Purchase Plan (the “Plan”) of Ironwood Pharmaceuticals, Inc. (the “Company”). 1. Purpose. The purpose of the Plan is to provide Employees of the Company and its Designated Subsidiaries with an opportunity ... WebMar 24, 2024 · IRONWOOD PHARMACEUTICALS, INC. company earnings calendar and analyst expectations - Upcoming and past events Nasdaq: IRWD Nasdaq. ... Stock quotes are provided by Factset, Morningstar and S&P Capital IQ 1 MarketScreener is worth more than 1000 Influencers! 100% Free Registration osteoarthritis 30 years old
Ironwood Pharmaceuticals : Announces Filing by Astellas of New …
WebApr 5, 2024 · The latest price target for . Ironwood Pharmaceuticals (NASDAQ: IRWD) was reported by Piper Sandler on April 22, 2024.The analyst firm set a price target for $16.00 expecting IRWD to rise to ... WebStock analysis for Ironwood Pharmaceuticals Inc (IRWD:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. WebIronwood Pharmaceuticals is an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases. Cambridge, Massachusetts, United States 501-1000 Post-IPO Debt Public www.ironwoodpharma.com 24,278 Actively Hiring - View All Jobs Highlights Stock Symbol NASDAQ:IRWD Total Funding Amount $634M Contacts 298 osteoarthritis 20 years old